Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Mechanisms of Action: Physiological Effects

Symmetry Requirements for Effective Blocking of Pore-Forming Toxins: Comparative Study with α-, β-, and γ-Cyclodextrin Derivatives

Konstantina Yannakopoulou, Laszlo Jicsinszky, Crysie Aggelidou, Nikolaos Mourtzis, Tanisha M. Robinson, Adiamseged Yohannes, Ekaterina M. Nestorovich, Sergey M. Bezrukov, Vladimir A. Karginov
Konstantina Yannakopoulou
1Institute of Physical Chemistry, National Center for Scientific Research Demokritos, Aghia Paraskevi 15310, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laszlo Jicsinszky
2CYCLOLAB R&D Laboratories Ltd., Illatos ut. 7, H-1097 Budapest, Hungary
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Crysie Aggelidou
1Institute of Physical Chemistry, National Center for Scientific Research Demokritos, Aghia Paraskevi 15310, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nikolaos Mourtzis
1Institute of Physical Chemistry, National Center for Scientific Research Demokritos, Aghia Paraskevi 15310, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tanisha M. Robinson
3Innovative Biologics, Inc., 13455 Sunrise Valley Dr., Suite 200, Herndon, Virginia 20171
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adiamseged Yohannes
3Innovative Biologics, Inc., 13455 Sunrise Valley Dr., Suite 200, Herndon, Virginia 20171
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ekaterina M. Nestorovich
4Program in Physical Biology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892
5The Catholic University of America, 620 Michigan Ave., N.E., Washington, DC 20064
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sergey M. Bezrukov
4Program in Physical Biology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vladimir A. Karginov
3Innovative Biologics, Inc., 13455 Sunrise Valley Dr., Suite 200, Herndon, Virginia 20171
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: vak@innovbio.com
DOI: 10.1128/AAC.01764-10
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

We compared the abilities of structurally related cationic cyclodextrins to inhibit Bacillus anthracis lethal toxin and Staphylococcus aureus α-hemolysin. We found that both β- and γ-cyclodextrin derivatives effectively inhibited anthrax toxin action by blocking the transmembrane oligomeric pores formed by the protective antigen (PA) subunit of the toxin, whereas α-cyclodextrins were ineffective. In contrast, α-hemolysin was selectively blocked only by β-cyclodextrin derivatives, demonstrating that both symmetry and size of the inhibitor and the pore are important.

INTRODUCTION

Previously, we proposed a novel approach for the discovery of inhibitors of pore-forming toxins that involves the blockage of the pores using molecules with comparable dimensions and the same symmetry as the target pores. It allows for the identification of lead compounds faster and significantly more cheaply in comparison with the existing industry standards. First, this approach was successfully tested on anthrax lethal toxin (LeTx), which plays a key role in anthrax infection. The toxin was disabled by the blockage of the pore formed by protective antigen (PA63), an essential component of anthrax toxin, by rationally designed compounds. Based on the 7-fold symmetry of the PA63 pore, we synthesized and tested cyclic molecules that had 7-fold symmetry using β-cyclodextrin (β-CD) as a starting molecule (Fig. 1). The discovered inhibitors of anthrax toxin were successfully tested in vitro and in vivo (1–5, 7, 10). The broader applicability of this approach was demonstrated using as targets two other toxins that form transmembrane pores with 7-fold symmetry: α-hemolysin (α-HL) of Staphylococcus aureus (2, 11) and ε-toxin produced by Clostridium perfringens (unpublished data).

Fig. 1.
  • Open in new tab
  • Download powerpoint
Fig. 1.

Schematic illustration of α-, β-, and γ-cyclodextrin molecules in comparison with staphylococcal α-HL channel (left) and anthrax PA (right) prepore. The sizes of cyclodextrin molecules are taken from reference 12.

To investigate how the structural features of the pore blockers affect their activities, we evaluated the ability of structurally related derivatives of α-, β-, and γ-cyclodextrins to inhibit the cytotoxic activities of anthrax lethal toxin (LeTx) and staphylococcal α-HL as well as to block the ion current through the channels formed by PA63 and α-HL in planar lipid membranes.

The structures of the compounds tested in this study are presented in Table 1. The synthesis of compounds 8, 9, and 11 to 17 (8, 9) as well as compounds 19 (3) and 22 (2) was described previously. The preparation of compounds 1 to 7, 10, 18, 20, 21, and 23 is presented in the supplemental material. Compounds 1 to 20 were tested for their ability to protect mouse macrophage RAW 264.7 cells from LeTx-induced cell death as described in our earlier publications (2–4). Inhibition of the cytotoxic activity of α-HL was evaluated using a rabbit erythrocyte cell lysis assay as described in reference 2. For some of these compounds, we also evaluated their ability to block the ion current through the pores formed by PA63 and α-HL in planar lipid membranes (2).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 1.

Activities of the compounds in this study against LeTx or PA (compounds 1 to 20) and α-HL (compounds 21 to 23)

Anthrax toxin inhibition.First, we compared the activities of per-6-amino derivatives carrying unmodified hydroxyl groups at positions 2 and 3 (compounds 1 to 3) with the 2,3-methylated ones (compounds 4 to 6; Fig. 1 shows OH group numberings) (Table 1). None of the methylated derivatives displayed toxin-inhibiting activities, while the unmodified compounds 2 and 3 showed activity at low-micromolar concentrations. These data demonstrate the importance of the H-bonding network for the rigidness of the cyclodextrin core, which is destroyed by methylation of the hydroxyl groups at positions 2 and 3.

We also investigated the activities of various α-, β-, and γ-cyclodextrin derivatives carrying the same modifications. Similarly to results obtained earlier (3), the α-cyclodextrin derivatives showed no (compounds 1, 7, 10, and 13) or low (compound 18) LeTx-inhibiting activity. This finding could be explained by their smaller size or by the features of α-CD's structure, which could provide a less favorable spatial orientation of the substituting groups due to the mismatch of the 6-fold symmetry of α-CD and the 7-fold symmetry of the PA63 pore.

All the β- and γ-cyclodextrin derivatives with free OH groups at positions 2 and 3 displayed anti-LeTx activity in the micromolar range. When we compared structurally similar derivatives of β- and γ-cyclodextrins, it appeared that in many instances the γ-CDs were more active than the β-CD derivatives (compounds 2 and 3, 8 and 9, 14 and 15, and 16 and 17). That could be related to the recently reported observation of PA63 octameric pores having the same 8-fold symmetry as γ-CD (6). It is interesting also that in the case of the structurally related amino and guanidino derivatives, the latter ones were more active (compounds 2 and 14, 3 and 15, 8 and 16, and 9 and 17).

The ability of several key compounds to block PA channels was tested in channel reconstitution experiments. The results showed (Table 1) that there is a general correlation between the cytotoxicity inhibition and channel blocking activity. Similarly to the results of the cytotoxicity experiments, α-CD derivatives (compounds 1, 13, and 18) exhibited a much lower blocking activity than the β- and γ-CD derivatives (compounds 2, 3, 14, 15, 19, and 20).

α-Hemolysin inhibition.We also evaluated the activities of two α- and γ-CDs (compounds 21 and 23) having the same substituents on the macrocycle's primary side as the β-CD derivative (compound 22) which inhibits α-HL (2). The compounds were tested using a rabbit erythrocyte assay. Both α- and γ-CD derivatives did not display any activity against α-HL. Similar results were obtained when we compared the compounds' abilities to block the pores formed by α-HL in planar lipid membranes.

The fact that only derivative 22 with the 7-fold symmetry blocked the heptameric α-HL pore is consistent with the idea that a symmetry match between the blocking molecule and the pore is required for effective inhibition. The difference in the activities of γ-CD derivatives against anthrax and staphylococcal toxins could be explained by the recent observation that in contrast to α-HL, PA presumably can form octameric pores in addition to heptameric ones (6). However, the currently available data are ambiguous. For example, our ion channel measurements showed that both β-CD and γ-CD derivatives independently and completely blocked all PA channels in the planar lipid membranes, bringing the transmembrane current to zero. Earlier we reported two types of PA channel insertions (10) that might be attributed to heptameric and octameric channel formation, but the kinetic characteristics of β-CD binding to these channels were indistinguishable. It should be taken into account that in the channel reconstitution experiments only transmembrane pore blockage is detected. The cell toxicity inhibition could be more complex and also involve inactivation of the prepore. Further studies are required to elucidate the fine mechanisms of the heptameric and octameric pore formations and their relative ratios in the prepores and transmembrane pores as well as the parameters of binding of cyclodextrin derivatives to those forms. To conclude, these data showed that size and conformation as well as the match of the symmetry of a blocking molecule and a pore play important roles in the activity of the inhibitors of pore-forming toxins.

ACKNOWLEDGMENTS

This research was supported by grant 2R44AI052894-02 from the NIH; by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, and the National Institute of Allergy and Infectious Diseases (NIAID) intramural biodefense research grant for an institute other than NIAID; and by the program ARISTEIA (“Excellence in Research Institutes” of the Greek GSRT).

FOOTNOTES

    • Received 16 December 2010.
    • Returned for modification 18 February 2011.
    • Accepted 25 April 2011.
    • Accepted manuscript posted online 9 May 2011.
  • ↵† Supplemental material for this article may be found at http://dx.doi.org/10.1128/AAC.01764-10.

  • Copyright © 2011, American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Backer M. V.,
    2. et al
    . 2007. Inhibition of anthrax protective antigen outside and inside the cell. Antimicrob. Agents Chemother. 51:245–251.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Karginov V. A.,
    2. et al
    . 2007. Inhibition of S. aureus α-hemolysin and B. anthracis lethal toxin by β-cyclodextrin derivatives. Bioorg. Med. Chem. 15:5424–5431.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Karginov V. A.,
    2. et al
    . 2006. Search for cyclodextrin-based inhibitors of anthrax toxins: synthesis, structural features, and relative activities. Antimicrob. Agents Chemother. 50:3740–3753.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Karginov V. A.,
    2. et al
    . 2006. β-Cyclodextrin derivatives that inhibit anthrax lethal toxin. Bioorg. Med. Chem. 14:33–40.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Karginov V. A.,
    2. Nestorovich E. M.,
    3. Moayeri M.,
    4. Leppla S. H.,
    5. Bezrukov S. M.
    . 2005. Blocking anthrax lethal toxin at the protective antigen channel by using structure-inspired drug design. Proc. Natl. Acad. Sci. U. S. A. 102:15075–15080.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Kintzer K. F.,
    2. et al
    . 2009. The protective antigen component of anthrax toxin forms functional octameric complexes. J. Mol. Biol. 392:614–629.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    1. Moayeri M.,
    2. Robinson T. M.,
    3. Leppla S. H.,
    4. Karginov V. A.
    . 2008. In vivo efficacy of β-cyclodextrin derivatives against anthrax lethal toxin. Antimicrob. Agents Chemother. 52:2239–2241.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Mourtzis N.,
    2. Paravatou M.,
    3. Mavridis I. M.,
    4. Roberts M. L.,
    5. Yannakopoulou K.
    . 2008. Synthesis, characterisation, and remarkable biological properties of cyclodextrins bearing guanidinoalkylamino and aminoalkylamino groups on their primary side. Chem. Eur. J. 14:4188–4200.
    OpenUrlCrossRef
  9. 9.↵
    1. Mourtzis M.,
    2. et al
    . 2007. Synthesis and characterization of per(6-guanidino-6-deoxy)cyclodextrins and studies of their effect on DNA. Org. Biomol. Chem. 5:125–131.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Nestorovich E. M.,
    2. Karginov V. A.,
    3. Berezhkovskii A. M.,
    4. Bezrukov S. M.
    . 2010. Blockage of anthrax PA63 pore by a multi-charged high-affinity toxin inhibitor. Biophys. J. 99:134–143.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Ragle B. E.,
    2. Karginov V. A.,
    3. Wardenburg J. B.
    . 2010. Prevention and treatment of Staphylococcus aureus pneumonia with a β-cyclodextrin derivative. Antimicrob. Agents Chemother. 54:298–304.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Szejtli J
    . 1998. Introduction and general overview of cyclodextrin chemistry. Chem. Rev. 98:1743–1753.
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top
Download PDF
Citation Tools
Symmetry Requirements for Effective Blocking of Pore-Forming Toxins: Comparative Study with α-, β-, and γ-Cyclodextrin Derivatives
Konstantina Yannakopoulou, Laszlo Jicsinszky, Crysie Aggelidou, Nikolaos Mourtzis, Tanisha M. Robinson, Adiamseged Yohannes, Ekaterina M. Nestorovich, Sergey M. Bezrukov, Vladimir A. Karginov
Antimicrobial Agents and Chemotherapy Jun 2011, 55 (7) 3594-3597; DOI: 10.1128/AAC.01764-10

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Symmetry Requirements for Effective Blocking of Pore-Forming Toxins: Comparative Study with α-, β-, and γ-Cyclodextrin Derivatives
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Symmetry Requirements for Effective Blocking of Pore-Forming Toxins: Comparative Study with α-, β-, and γ-Cyclodextrin Derivatives
Konstantina Yannakopoulou, Laszlo Jicsinszky, Crysie Aggelidou, Nikolaos Mourtzis, Tanisha M. Robinson, Adiamseged Yohannes, Ekaterina M. Nestorovich, Sergey M. Bezrukov, Vladimir A. Karginov
Antimicrobial Agents and Chemotherapy Jun 2011, 55 (7) 3594-3597; DOI: 10.1128/AAC.01764-10
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596